A standard panel drug test is a urine screening that checks for five specific classes of drugs, commonly called a 5-panel test. It’s the baseline required for all federal workplace testing and the most widely used format across private employers, and it screens for marijuana, cocaine, opiates, amphetamines, and PCP. Larger panels (7, 10, or 12) build on this same foundation by adding more substances.
The Five Drug Classes on a Standard Panel
The federal government sets the standard through the Substance Abuse and Mental Health Services Administration (SAMHSA), and every federally mandated drug test uses the same five categories. Each category has a specific concentration threshold that must be reached before the test is considered positive:
- Marijuana (THC): Screens for the main metabolite your body produces after using cannabis. The initial screening threshold is 50 ng/mL.
- Cocaine: Detects benzoylecgonine, the compound cocaine breaks down into. Initial threshold is 150 ng/mL.
- Opiates: Targets codeine and morphine (which also captures heroin, since heroin metabolizes into morphine). Threshold is 2,000 ng/mL.
- Amphetamines: Covers both amphetamine and methamphetamine. Threshold is 500 ng/mL.
- PCP (phencyclidine): Threshold is 25 ng/mL.
These cutoff levels exist to reduce false positives. Trace amounts from passive exposure or normal dietary sources generally won’t reach them.
What Larger Panels Add
A 10-panel test includes everything in the 5-panel plus five additional substance categories: barbiturates, benzodiazepines (such as Xanax or Valium), methadone, methaqualone, and propoxyphene. These expanded panels are more common in healthcare, law enforcement, and jobs involving public safety. Some employers use 7-panel or 12-panel variations depending on their industry and concerns.
One notable change on the horizon: the Department of Transportation proposed in September 2025 to add fentanyl and its metabolite norfentanyl to both urine and oral fluid testing panels. If finalized, this would be the first expansion of the DOT’s core drug list in years, reflecting the scale of the synthetic opioid crisis. The standard 5-panel’s opiate category does not currently detect fentanyl, because fentanyl is a synthetic opioid with a different chemical structure than codeine or morphine.
How the Two-Step Testing Process Works
Standard panel testing uses a two-step approach. The first step is a rapid screening called an immunoassay. It uses antibodies that react to drug metabolites in your urine sample. This step is fast and inexpensive, but it’s not perfectly precise. It can sometimes flag substances that are chemically similar to the target drug, which is why a second step exists.
If the immunoassay comes back positive, the same sample goes through confirmatory testing using a technique called gas chromatography-mass spectrometry. This method physically separates and identifies the exact molecules in the sample, making it far more accurate. A result is only reported as positive after both steps agree. The confirmatory cutoffs are typically lower than the initial screen, so the confirmation test is actually more sensitive, not less.
Detection Windows by Substance
How far back a urine test can detect use depends heavily on the substance and how often you use it. For a single dose of most drugs, urine testing picks up use within roughly 1.5 to 4 days. Chronic users can test positive for about a week after their last use, sometimes longer.
Marijuana is the major exception. Because THC metabolites are fat-soluble, they accumulate in body tissue and release slowly. Occasional users may clear a test in a few days, but frequent, heavy users can test positive for a month or more. Cocaine, opiates, amphetamines, and PCP typically clear faster, usually within 2 to 4 days for single or occasional use.
Urine, Hair, and Oral Fluid Compared
Urine is the default specimen for standard panel testing because it’s accurate, reliable, and cheap to process. Most drugs besides THC only remain detectable in urine for a few days, though, which makes urine testing best suited for catching relatively recent use.
Hair testing offers a much longer window. Drugs can be detected in hair samples for months, making it useful when employers or legal systems want to evaluate a longer pattern of use rather than a snapshot. The tradeoff is that it takes 7 to 10 days for new hair growth to reach a cuttable length, so hair testing can actually miss very recent use. Research comparing the two methods found that urine testing was significantly better at catching recent marijuana use (74% vs. 23%) and benzodiazepine use (51% vs. 15%), while hair testing was substantially better at detecting cocaine use (66% vs. 48%).
Oral fluid (saliva) testing has the shortest detection window, typically hours to a few days. It’s useful for post-accident or reasonable-suspicion testing when the question is whether someone used very recently.
Common Causes of False Positives
The initial immunoassay screen is susceptible to cross-reactivity with certain medications and even some everyday products. Knowing what can trigger a false positive matters if you’re taking any of these before a test.
For the amphetamine category, common culprits include pseudoephedrine (found in many cold medications), the antidepressant bupropion, the weight-loss drug phentermine, and methylphenidate (used for ADHD). The marijuana screen has been triggered by ibuprofen, naproxen, and surprisingly, certain baby wash products. For opiates, dextromethorphan (found in cough suppressants), diphenhydramine (the active ingredient in Benadryl), and poppy seeds are all documented causes of false positives.
The PCP screen is particularly prone to interference. Dextromethorphan, diphenhydramine, tramadol, ketamine, and the antidepressant venlafaxine have all been reported to trigger false positives. This is one reason the confirmatory second step is so important. If you’re taking any prescription or over-the-counter medication, you can disclose it to the testing facility’s review officer so it can be considered when interpreting results.
How Sample Collection Works
For federally regulated tests, the collection follows a strict chain of custody protocol designed to ensure the sample can’t be tampered with or swapped. Every step from collection to lab analysis is documented. Your sample container gets a unique identification code along with the date, time, location, and collector’s signature. The sample is sealed in tamper-evident packaging, and every person who handles it signs and dates a chain of custody form.
This documentation exists so the results hold up legally. If any link in the chain is broken, such as a missing signature, an unsealed container, or unaccounted time, the test result can be challenged. For non-regulated private employer tests, the process is often similar but may be less rigorous depending on state laws and company policy.
You’ll typically provide your sample at a certified collection site, not at your employer’s office. The collector may check the temperature of the sample to verify it’s fresh, and the restroom often has blue dye in the toilet water and limited access to running water to prevent dilution or substitution.